RBC Capital Maintains Sector Perform on NeueHealth, Raises Price Target to $8
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Ben Hendrix has maintained a 'Sector Perform' rating on NeueHealth (NYSE:NEUE) and increased the price target from $7 to $8.
March 13, 2024 | 3:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital has maintained its 'Sector Perform' rating on NeueHealth and raised the price target from $7 to $8.
The increase in price target by RBC Capital suggests a positive outlook on NeueHealth's stock, potentially leading to increased investor confidence and a short-term rise in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100